ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OPTN OptiNose Inc

1.12
-0.01 (-0.88%)
25 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
OptiNose Inc OPTN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.88% 1.12 09:13:19
Open Price Low Price High Price Close Price Previous Close
1.15 1.09 1.15 1.11 1.13
more quote information »

Recent News

Date Time Source Heading
21/5/202406:16EDGAR2Form 8-K - Current report
21/5/202404:33EDGAR2Form D - Notice of Exempt Offering of Securities
18/5/202402:00GLOBEOptinose to Present at the H.C. Wainwright 2nd Annual..
14/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202421:08EDGAR2Form 8-K - Current report
14/5/202421:00GLOBEOptinose Reports First Quarter 2024 Financial ResultsĀ and..
11/5/202404:56GLOBEOptinose Announces Reporting Date for First Quarter 2024..
09/5/202421:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202421:04EDGAR2Form 8-K - Current report
09/5/202421:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202421:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202421:00GLOBEOptinose Announces $55 Million Registered Direct Offering
25/4/202421:00GLOBEOptinose Provides Corporate Update on XHANCE Launch and..
05/4/202407:01GLOBEOptinose to Present at the Needham Virtual Healthcare..
16/3/202406:34GLOBEXHANCE Approved by FDA as First and Only Medication..
09/3/202408:10EDGAR2Form 8-K - Current report
08/3/202408:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202423:00GLOBEOptinose Reports Fourth Quarter and Full Year 2023 Financial..
07/3/202423:00EDGAR2Form 8-K - Current report
01/3/202408:40GLOBEOptinose Announces Reporting Date for Fourth Quarter 2023..
01/3/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:08EDGAR2Form 8-K - Current report
23/2/202408:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202412:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202404:00GLOBEOptinose Announces the Publication of ReOpen Phase 3..
22/12/202308:11EDGAR2Form 8-K - Current report
21/12/202304:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202304:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202300:48DJNOptinose Shares Slide Premarket as FDA Extends Xhance Review
06/12/202323:02EDGAR2Form 8-K - Current report
06/12/202323:00GLOBEOptinose Announces 3-Month Extension of FDA Review Period..
23/11/202301:00GLOBEOptinose to Present at the 35th Annual Piper Sandler..
09/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:02EDGAR2Form 8-K - Current report
09/11/202323:00GLOBEOptinose Reports Third Quarter 2023 Financial Results and..
27/10/202323:00GLOBEOptinose Announces Reporting Date for Third Quarter 2023..
22/9/202323:01GLOBEOptinose to Present at the 2023 Cantor Global Healthcare..
20/9/202309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202309:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202306:05EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202321:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202321:02EDGAR2Form 8-K - Current report
10/8/202321:00GLOBEOptinose Reports Second Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock